110
Participants
Start Date
October 31, 2005
Primary Completion Date
August 31, 2007
Study Completion Date
August 31, 2007
Rituximab
Aldesleukin
Fairfax Northern VA Hem-Onc PC, Fairfax
Virginia Oncology Associates, Norfolk
Onc and Hem Associates of SW VA, Inc., Salem
Cancer Centers of the Carolinas, Greenville
Greater Dayton Cancer Center, Kettering
Minnesota Oncology Hematology, PA, Minneapolis
Hematology Oncology Associates of IL, Chicago
Cancer Care & Hematology Specialists of Chicagoland, Niles
Kansas City Cancer Centers-Central, Kansas City
Texas Oncology, PA, Garland
Texas Cancer Center at Medical City, Dallas
Longview Cancer Center, Longview
Tyler Cancer Center, Tyler
Texas Cancer Center, Arlington
San Antonio Tumor & Blood Clinic, Fredericksburg
El Paso Cancer Treatment Ctr, El Paso
Rocky Mountain Cancer Center-Midtown, Denver
Puget Sound Cancer Center-Edmonds, Edmonds
Pudget Sound Cancer Center-Seattle, Seattle
Yakima Valley Mem Hosp/North Star Lodge, Yakima
Cancer Care Northwest-North, Spokane
Collaborators (1)
Chiron Corporation
INDUSTRY
Fred Hutchinson Cancer Center
OTHER
US Oncology Research
INDUSTRY